Latest Information Update: 17 Nov 2003
At a glance
- Originator Showa Yakuhin Kako; Toyama Chemical
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Periodontal disorders
Most Recent Events
- 07 Jan 2002 New profile
- 07 Jan 2002 Investigation in Periodontal disorders in Japan (Topical)